Skip to main content
OpenTrials
Completed

NCT Number: NCT03487146

HP Improves Sleep and Overall Survival Rate in Maintenance Hemodialysis Patients

Sleep disturbance has been long-standing torments in most of patients with maintenance hemodialysis (HD). In this study, we attempted to explore whether long-term hemoperfusion (HP) could improve sleep disorder and increase overall survival rate in HD patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • duration of maintenance HD should be equal or more than 3 months,
  • patient's age should be equal or more than 18 years

Exclusion criteria

  • i) he/she diagnosed with malignant tumors, an active rheumatism, infectious diseases, or a severe heart failure ii) he/she would disagree with the study
  • he/she has received a short-term poor prognosis
  • he/she would be more than 80 years old

Treatment and study plan

hemoperfusion(HP)

Device

These patients were computer-matched into two groups, involving 100 patients with absolute HD vs. 100 cases with HD+HP.HP was performed 1-2 times/per 2 weeks, and each session lasted for two hours.Self-reported sleep disturbance was evaluated before and after observational time (two-year period), which lasted at least 7 hours based on the recommendations presented by National Institute of Health (NIH). Sleep efficiency (%) was calculated as the ratio of sleep duration to total time in bed, and was multiplied by 100.

Primary outcomes

  1. improvement of self-reported sleep disturbance

    Time frame: 2 years

    Analysis of the sleep disturbance by using Pittsburgh Sleep Quality Index (PSQI) questionnaire

Secondary outcomes

  1. survival

    Time frame: 2 years

    increase overall survival rate

Sponsors and collaborators

Lead sponsor

Shanghai Pudong Hospital

Other

Registry information

Official study title

Hemoperfusion in Combination With Hemodialysis for Improvement of Self-reported Sleep Disturbance and Overall Survival Rate in Maintenance Hemodialysis Patients

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Apr 3, 2018
Registry last updated
Apr 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.